*Part, Chapter, Paragraph*

1 I, 2. 6 | the average EU student **ratio** is expected to decline by
2 I, 2. 6 | points. Declines in this **ratio** are expected in all countries
3 I, 3. 3 | since their total dependency **ratio** is currently at the lowest
4 I, 3. 3 | old-age dependency — the **ratio** of the number of older,
5 I, 3. 3 | of the old-age dependency **ratio** within the European Union
6 I, 3. 3 | the old-age-dependency **ratio** rose by 2.8% in the period
7 I, 3. 3 | corresponds to the second highest **ratio** after Italy.~ ~According
8 I, 3. 3 | the old-age dependency **ratio** for EU15 will rise on average
9 II, 4. 1 | life is provided by the **ratio** HLY to LE which measures
**10** II, 4. 1 | limitations (LEwSL) and the **ratio** of life expectancy to the
11 II, 4. 1 | DFLE65 ) at 65 as well as the **ratio** DFLE65 /LE65 computed from
12 II, 5. 1. 1| population, aged 46 to 77, odds **ratio** associated with smoking
13 II, 5. 4. 2| defined by EUCID as the **ratio** of the number of cases of
14 II, 5. 4. 2| retinopathy is defined as the **ratio** of the number of new cases
15 II, 5. 5. 1| Figure 5.5.1.2. Odds **ratio** (with 95% confidence interval)
16 II, 5. 5. 1| distress.~ ~Table 5.5.1.5. Odds **Ratio** for a score MH5<55 by a
17 II, 5. 5. 1| Figure 5.5.1.3. Odds **ratio** (with 95% confidence interval)
18 II, 5. 5. 1| Figure 5.5.1.4. Odds **ratio** (with 95% confidence interval)
19 II, 5. 5. 3| SMR~Standardized Mortality **Ratio**~ ~
**20** II, 5. 5. 3| native-born individuals (**ratio** 1.84), and lower in the
21 II, 5. 5. 3| populations (male:female **ratio** = 1.4); moreover, not only
22 II, 5. 5. 3| the standardized mortality **ratio** (SMR) for people with schizophrenia
23 II, 5. 5. 3| No. of cases ~Prevalence **ratio** (per 1,000)~Reference(s),
24 II, 5. 5. 3| Standardized mortality **ratio**; (*) Reference listed in
25 II, 5. 5. 3| seizure-related accidents (rate **ratio**, RR 1.8)(Vaa, 2005) and
26 II, 5. 5. 3| Antiepileptic Drug~CFR~Case Fatality **Ratio**~IBE~International Bureau
27 II, 5. 5. 3| Proportionate Mortality **Ratio**~SEWGED~Second European Working
28 II, 5. 5. 3| SMR~Standardized Mortality **Ratio**~SUDEP~Sudden Unexplained
29 II, 5. 5. 3| 69 and with a woman:man **ratio** of 2.0. In the same study
**30** II, 5. 5. 3| SMR~Standardized Mortality **Ratio**~ ~ ~ ~
31 II, 5. 6. 3| obesity to result in an odds **ratio** of about 8.0 for developing
32 II, 5. 6. 3| higher in women than men (the **ratio** varied from 1.7 to 4.0) .~ ~
33 II, 5. 6. 3| female to male incidence **ratio** of approximately 2:1 (EULAR
34 II, 5. 6. 3| age-adjusted female to male **ratio** being 4:1), and around 50%
35 II, 5. 8. 4| population, aged 46 to 77, odds **ratio** associated with smoking
36 II, 5. 8. 4| chronic cough and phlegm (odds **ratio** 1.22 compared to males) (
37 II, 5. 9. 3| increase (incident rate **ratio** = 2.63 and 95% CI = 2.20-
38 II, 5. 9. 4| change in the male to female **ratio**. In order to confirm this
39 II, 5. 9. 4| confirm this change in the sex **ratio**, a Scottish study questionnaire
**40** II, 5. 9. 4| years the male to female **ratio** (M:F) significantly narrowed
41 II, 5. 9. 4| the narrowing of the sex **ratio**, but other factors such
42 II, 5. 9. 4| effect: the adjusted odds **ratio** (OR) for current rhino-conjunctivitis
43 II, 5. 9. 4| asthma and female sex (odds **ratio**, OR = 0.5); presence of
44 II, 5. 9. 4| asthma (prevalence odds **ratio**, POR = 0.39; 95% CI: 0.23-
45 II, 5. 9. 5| assessment of the cost-benefit **ratio** of therapy and management
46 II, 5. 10. 3| adults, the female to male **ratio** being around 3:2 in the
47 II, 5. 11. 3| 2001). The death incidence **ratio** is strikingly different
48 II, 5. 14. 6| optimize the cost-effectiveness **ratio** of the health programmes
49 II, 6. 3. 3| than in men (female to male **ratio**, 1.5:1).~ ~A specific variant
**50** II, 6. 3. 3| in women (male to female **ratio**, 4.4:1).~ ~Neonatal syphilis
51 II, 6. 3. 3| than women (male to female **ratio**, 2.3:1).~ ~ ~HBV vaccination
52 II, 6. 3. 4| in males (male to female **ratio**, 1.7:1). Cases aged over
53 II, 9. 1. 1| health~ C: Maternal mortality **ratio** by age, mode of delivery~
54 II, 9. 1. 2| statistics).~ ~Table 9.1.2.3. **Ratio** of Terminations of Pregnancy
55 II, 9. 1. 2| country, 2000-2004~ ~The **ratio** of TOPFA to births varies
56 II, 9. 1. 2| gestation. The highest TOPFA **ratio** both before and after 20
57 II, 9. 3. 2| the maternal mortality **ratio**, as well as two recommended
58 II, 9. 3. 2| The maternal mortality **ratio** is a complex fraction in
59 II, 9. 3. 2| the maternal mortality **ratio** in the European Union has
**60** II, 9. 3. 2| Romania, which had the highest **ratio** in Europe, between 140 and
61 II, 9. 3. 2| liberalisation of abortion act, the **ratio** declined to 26 per 100 000
62 II, 9. 3. 2| 2.2. Maternal mortality **ratio** in selected EUGLOREH countries
63 II, 9. 3. 2| 23% with a case-fatality **ratio** ranging from 0.02-37%.~ ~
64 II, 9. 4. 3| continent: where the dependency **ratio** (number of people aged 65
65 III, 10. 5. 2| the dependency rates (the **ratio** of the elderly population
66 III, 10. 5. 2| long-term illness, the Odds **Ratio** was at 0.93 for intermediate
67 III, 10. 6. 2| Table 10.6.2.1. Odds **Ratio** Chronic diseases in eight
68 IV, 11. 3. 1| latest available year~ ~The **ratio** of practising doctors per
69 IV, 11. 6. 3| financing would be one where the **ratio** of total health contribution